School of Cancer Sciences

Dr Conchita Vens

  • Reader in Translational Radiobiology (Clinical Research Garscube)

telephone: 01413304665
email: Conchita.Vens@glasgow.ac.uk
pronouns: She/her/hers

School of Cancer Science, Wolfson Wohl Cancer Research Centre, Bearsden, Glasgow, G61 1BD

Import to contacts

Research interests

Research groups

Publications

List by: Type | Date

Jump to: 2026 | 2025 | 2024 | 2023 | 2022
Number of items: 6.

2026

Anderson, S. et al. (2026) Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study – Study protocol. Clinical and Translational Radiation Oncology, 60, 101245. (doi: 10.1016/j.ctro.2026.101245) (PMID:42568775)

2025

Inanc, B. et al. (2025) TRIP12's role in the governance of DNA polymerase β involvement in DNA damage response and repair. Nucleic Acids Research, 53(12), gkaf574. (doi: 10.1093/nar/gkaf574) (PMID:40613707) (PMCID:PMC12231584)

2024

Vens, C. et al. (2024) A joint physics and radiobiology DREAM team vision - towards better response prediction models to advance radiotherapy. Radiotherapy and Oncology, 196, 110277. (doi: 10.1016/j.radonc.2024.110277) (PMID:38670264)

Ahmadian, M. et al. (2024) Overcoming data scarcity in radiomics/radiogenomics using synthetic radiomic features. Computers in Biology and Medicine, 174, 108389. (doi: 10.1016/j.compbiomed.2024.108389) (PMID:38593640)

2023

Van der Hulst, H. J. et al. (2023) The prediction of biological features using magnetic resonance imaging in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Cancers, 15(20), 5077. (doi: 10.3390/cancers15205077) (PMID:37894447) (PMCID:PMC10605807)

2022

van der Wiel, Alexander M. A., Schuitmaker, Lesley, Cong, Ying, Theys, Jan, Van Hoeck, Arne, Vens, Conchita, Lambin, Philippe, Yaromina, Ala and Dubois, Ludwig J. (2022) Homologous recombination deficiency scar: mutations and beyond—implications for precision oncology. Cancers, 14(17), 4157. (doi: 10.3390/cancers14174157) (PMID:36077694) (PMCID:PMC9454578)

This list was generated on Sat Aug 22 07:11:25 2026 BST.
Jump to: Articles
Number of items: 6.

Articles

Anderson, S. et al. (2026) Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study – Study protocol. Clinical and Translational Radiation Oncology, 60, 101245. (doi: 10.1016/j.ctro.2026.101245) (PMID:42568775)

Inanc, B. et al. (2025) TRIP12's role in the governance of DNA polymerase β involvement in DNA damage response and repair. Nucleic Acids Research, 53(12), gkaf574. (doi: 10.1093/nar/gkaf574) (PMID:40613707) (PMCID:PMC12231584)

Vens, C. et al. (2024) A joint physics and radiobiology DREAM team vision - towards better response prediction models to advance radiotherapy. Radiotherapy and Oncology, 196, 110277. (doi: 10.1016/j.radonc.2024.110277) (PMID:38670264)

Ahmadian, M. et al. (2024) Overcoming data scarcity in radiomics/radiogenomics using synthetic radiomic features. Computers in Biology and Medicine, 174, 108389. (doi: 10.1016/j.compbiomed.2024.108389) (PMID:38593640)

Van der Hulst, H. J. et al. (2023) The prediction of biological features using magnetic resonance imaging in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Cancers, 15(20), 5077. (doi: 10.3390/cancers15205077) (PMID:37894447) (PMCID:PMC10605807)

van der Wiel, Alexander M. A., Schuitmaker, Lesley, Cong, Ying, Theys, Jan, Van Hoeck, Arne, Vens, Conchita, Lambin, Philippe, Yaromina, Ala and Dubois, Ludwig J. (2022) Homologous recombination deficiency scar: mutations and beyond—implications for precision oncology. Cancers, 14(17), 4157. (doi: 10.3390/cancers14174157) (PMID:36077694) (PMCID:PMC9454578)

This list was generated on Sat Aug 22 07:11:25 2026 BST.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • INDEPTH: INtegrated DEep molecular Phenotyping to improve Treatment outcomes in Head and neck cancer patients
    Office of the Chief Scientific Adviser
    2026 - 2028
     
  • Edinburgh-Glasgow Brain Tumour Centre of Excellence: Advanced Therapies for Glioblastoma
    Brain Tumour Research
    2024 - 2029
     
  • Characterisation of GBM-specific overexpression of DNA polymerase beta and its potential role in mitochondrial DNA repair.
    Cancer Research UK
    2023 - 2023
     
  • Advancing sustainable forage-based livestock production systems in Colombia
    Beatson Cancer Charity
    2022 - 2024
     
  • Overcoming hypoxia mediated resistance to radiotherapy-PARP inhibitor combinations inglioblastoma.
    Cancer Research UK
    2022 - 2023
     
  • Translational Radiotherapy research in HNSCC Workshop
    Cancer Research UK
    2022 - 2023